Literature DB >> 20916

A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma.

H Hörtnagl, C R Benedict, D G Grahame-Smith.   

Abstract

1 An existing radioenzymatic assay for plasma catecholamines using catechol-o-methyl transferase and [3H]-S-adenosyl-methionine has been modified resulting in a more sensitive assay for the measurement of plasma adrenaline and noradrenaline. 2 The lower limit of sensitivity for this method is 25 pg for adrenaline and 30 pg for noradrenaline/ml of plasma. 3 Resting supine (60 min) plasma adrenaline concentration was (mean +/- s.d.) 124 +/- 76 pg/ml(n=11) in males and 130 +/- 71 pg/ml (n=7) in females; plasma noradrenaline concentrations were respectively 444 +/- 129 pg/ml and 550 +/- 87 pg/ml. 4 The changes in plasma catecholamine concentrations in response to 40 degrees head-up tilt have been determined in a group of healthy normal subjects and have been shown to be related to changes in blood pressure and heart rate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20916      PMCID: PMC1429161          DOI: 10.1111/j.1365-2125.1977.tb00785.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  The binding of catecholamines to human serum proteins.

Authors:  G Powis
Journal:  Biochem Pharmacol       Date:  1975-03-15       Impact factor: 5.858

2.  A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.

Authors:  D P Henry; B J Starman; D G Johnson; R H Williams
Journal:  Life Sci       Date:  1975-02-01       Impact factor: 5.037

3.  The fate of H3-norepinephrine in animals.

Authors:  L G WHITBY; J AXELROD; H WEIL-MALHERBE
Journal:  J Pharmacol Exp Ther       Date:  1961-05       Impact factor: 4.030

4.  The physiological disposition of H3-epinephrine and its metabolite metanephrine.

Authors:  J AXELROD; H WEIL-MALHERBE; R TOMCHICK
Journal:  J Pharmacol Exp Ther       Date:  1959-12       Impact factor: 4.030

5.  Enzymatic O-methylation of epinephrine and other catechols.

Authors:  J AXELROD; R TOMCHICK
Journal:  J Biol Chem       Date:  1958-09       Impact factor: 5.157

6.  Reduced plasma norepinephrine response to standing in autonomic dysfunction.

Authors:  P E Cryer; S Weiss
Journal:  Arch Neurol       Date:  1976-04

7.  Plasma noradrenaline increases with age.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  Nature       Date:  1976-05-27       Impact factor: 49.962

8.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

9.  Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted.

Authors:  C J Mathias; N J Christensen; J L Corbett; H L Frankel; T J Goodwin; W S Peart
Journal:  Clin Sci Mol Med       Date:  1975-10

10.  Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques.

Authors:  E B Pedersen; N J Christensen
Journal:  Acta Med Scand       Date:  1975-11
View more
  16 in total

1.  Isolated ACTH deficiency. Metabolic and endocrine studies in a 7-year-old boy.

Authors:  A Aynsley-Green; M W Moncrieff; S Ratter; C R Benedict; C N Storrs
Journal:  Arch Dis Child       Date:  1978-06       Impact factor: 3.791

2.  Plasma catecholamines in hepatic coma and liver cirrhosis: role of octopamine.

Authors:  H Hörtnagl; H Lochs; G Kleinberger; J M Hackl; A F Hammerle; H Binder; F Wewalka
Journal:  Klin Wochenschr       Date:  1981-10-15

3.  Changes of dopamine beta-hydroxylase activity in human plasma during prolonged overactivity of the sympathetic nervous system in various diseases.

Authors:  H Hörtnagl; R Stadler-Wolffersgrün; T h Brücke; A F Hammerle; J M Hackl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

4.  Clinical significance of plasma adrenaline and noradrenaline concentrations in patients with subarachnoid haemorrhage.

Authors:  C R Benedict; A B Loach
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-02       Impact factor: 10.154

5.  Changes in plasma noradrenaline concentration as a measure of release rate.

Authors:  C R Benedict; M Fillenz; C Stanford
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

6.  Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation.

Authors:  E Appel; P Bayer; P Hajdú; D Palm; J Schofer; M Uihlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

7.  The activity of the sympathetic nervous system following severe head injury.

Authors:  H Hörtnagl; A F Hammerle; J M Hackl; T Brücke; E Rumpl; H Hörtnagl
Journal:  Intensive Care Med       Date:  1980-05       Impact factor: 17.440

8.  Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.

Authors:  C R Benedict; D G Grahame-Smith
Journal:  Br Heart J       Date:  1979-08

9.  In vivo release of endogenous catecholamines in the hypothalamus.

Authors:  A Philippu; H Dietl; J N Sinha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

10.  Dysfunction of the sympathetic nervous system in tetanus. A study of 3 cases.

Authors:  H Hörtnagl; T Brücke; J M Hackl
Journal:  Klin Wochenschr       Date:  1979-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.